IL137121A0 - Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha - Google Patents

Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha

Info

Publication number
IL137121A0
IL137121A0 IL13712199A IL13712199A IL137121A0 IL 137121 A0 IL137121 A0 IL 137121A0 IL 13712199 A IL13712199 A IL 13712199A IL 13712199 A IL13712199 A IL 13712199A IL 137121 A0 IL137121 A0 IL 137121A0
Authority
IL
Israel
Prior art keywords
heavy chain
light chain
alpha
antibody
variable
Prior art date
Application number
IL13712199A
Other languages
English (en)
Original Assignee
Miller Jonathan L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miller Jonathan L filed Critical Miller Jonathan L
Publication of IL137121A0 publication Critical patent/IL137121A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13712199A 1998-10-30 1999-10-29 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha IL137121A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10627598P 1998-10-30 1998-10-30
PCT/US1999/025495 WO2000026667A1 (fr) 1998-10-30 1999-10-29 Regions variables de chaine lourde et de chaine legere d'anticorps diriges contre la glycoproteine plaquettaire humaine ib alpha

Publications (1)

Publication Number Publication Date
IL137121A0 true IL137121A0 (en) 2001-06-14

Family

ID=22310524

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13712199A IL137121A0 (en) 1998-10-30 1999-10-29 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha

Country Status (8)

Country Link
EP (1) EP1051620B1 (fr)
JP (1) JP2002529054A (fr)
AT (1) ATE329263T1 (fr)
AU (1) AU1458500A (fr)
CA (1) CA2317808A1 (fr)
DE (1) DE69931756T2 (fr)
IL (1) IL137121A0 (fr)
WO (1) WO2000026667A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918788D0 (en) 1999-08-10 1999-10-13 Leuven K U Res & Dev Antithrombotic effect of platelet glycoprotein 1b blocking monoclonal Fab fragments
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
CA2490280A1 (fr) 2002-07-01 2004-01-08 Human Genome Sciences, Inc. Anticorps qui se lient specifiquement a reg iv
EP1539236A4 (fr) * 2002-07-03 2007-07-18 Univ Pennsylvania Compositions, procedes et kits ayant trait a des auto-anticorps antiplaquettaires et leurs inhibiteurs
WO2004044584A1 (fr) * 2002-11-13 2004-05-27 Micromet Ag Procede d'identification de cellules b specifiques d'un antigene
JP2007528711A (ja) * 2003-06-30 2007-10-18 バイオ−テクノロジー・ジェネラル（イスラエル）リミテッド 抗体及びその使用
EP1749536A1 (fr) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Stimulateurs activés du Facteur X et leur utilisation en tant qu'agents anti-hemorragiques pour l'usage topique
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US8323652B2 (en) 2008-11-14 2012-12-04 Canadian Blood Services Antibodies against GPIbα
ES2728115T3 (es) * 2009-10-30 2019-10-22 Janssen Biotech Inc Antagonistas de IL-17A
BR112022011226A2 (pt) * 2019-12-10 2022-08-30 Ccoa Therapeutics Inc Anticorpos antiglicoproteína ib alfa (gpibalpha) humanizados
JP2023507369A (ja) * 2019-12-20 2023-02-22 メディミューン，エルエルシー グリピカン３を標的とするキメラ抗原受容体を用いて癌を治療する組成物及び方法
KR20230027267A (ko) * 2020-06-23 2023-02-27 카드몬 코포레이션, 엘엘씨 항-pd-1 항체 및 융합 단백질

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877155A (en) * 1995-03-17 1999-03-02 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US5817748A (en) * 1995-03-17 1998-10-06 The Research Foundation Of State University Of New York Mimotopes of human Platelet glycoprotein Ib/IX

Also Published As

Publication number Publication date
EP1051620B1 (fr) 2006-06-07
JP2002529054A (ja) 2002-09-10
CA2317808A1 (fr) 2000-05-11
WO2000026667A9 (fr) 2001-04-12
WO2000026667A1 (fr) 2000-05-11
AU1458500A (en) 2000-05-22
DE69931756D1 (de) 2006-07-20
EP1051620A1 (fr) 2000-11-15
EP1051620A4 (fr) 2005-01-12
DE69931756T2 (de) 2007-05-24
ATE329263T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
IL137121A0 (en) Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
SE9201331D0 (sv) Protein l och hybridproteiner daerav
EP0724456A4 (fr) Anticorps diriges contre le cd40
EP0728215A4 (fr) PROCEDE DE LIAISON D'UN ELEMENT AU PEPTIDE -g(b)-AMYLO DE
WO1998050433A3 (fr) Anticorps monoclonaux humains contre le recepteur du facteur de croissance epidermique
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
UY35948A (es) Anticuerpos contra el receptor del factor de crecimiento similar a insulina
DK0866136T3 (da) Rekombinant bibliotekscreeningsfremgangsmåder
CR7343A (es) Anticuerpos para cd40
MX9504802A (es) Anticuerpos anti-egfr y fvs de cadena simple anti-egfr.
MXPA04001344A (es) Anticuerpos humanos antagonistas contra htnfsf13b.
WO2003060080A3 (fr) Domaines variable d'immunoglobuline canine, anticorps caninises, et procede de production et d'utilisation associes
RS80704A (en) ANTI- av?6.ANTIBODIES
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
MX9602971A (es) Anticuerpos humanizados contra la molecula vla-4 de adhesion de leucocitos.
EA201100128A1 (ru) АНТИТЕЛА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ К СВЯЗЫВАНИЮ С Fc-РЕЦЕПТОРОМ И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
DK0720624T3 (da) Omdirigering af antistoffer
AU2002951409A0 (en) Methods for regulating cancer
CA2457362A1 (fr) Anticorps monoclonaux humains neutralisant le virus de la rage et les procedes de fabrication et d'utilisation desdits anticorps
MX9702422A (es) Anticuerpos recombinantes contra fas y adn para los mismos.
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
SE9500148D0 (sv) Antibodies for use in cancer therapy and diagnosis
KR970005097A (ko) 암태아성 항원(cea)에 대한 단클론성 항체